Outset Medical
Outset Medical is reimagining dialysis for patients and providers, from the ICU to the home.
About Us - Outset Medical
Outset Medical is changing dialysis – one of the largest, most expensive, and stagnant areas of healthcare. Headquartered in San Jose, California, Outset operates across the United States and manufactures in North America.
Tablo Hemodialysis System - Outset Medical
INDICATIONS FOR USE: The Tablo ® Hemodialysis System and TabloCart™ is indicated for use in patients with acute and/or chronic renal failure, with or without ultrafiltration, in an acute or chronic care facility. Treatments must be administered under physician’s prescription and observed by a trained individual who is considered competent in the use of the device.
Outset Medical Announces $169 Million Private Placement …
SAN JOSE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it has entered into a definitive securities purchase agreement for a private placement of 843,908 shares ...
Take Charge of Your Dialysis with Tablo - Outset Medical
It’s able to fit easily in the home without looking like a piece of medical technology. All that’s needed is tap water and an electrical outlet — no dialysate batching required! Plus, an entire month of Tablo supplies fit in a small closet.
Improving Kidney Care for Providers - Outset Medical
Please email me about Tablo, Outset Medical, clinical studies, relevant information, and events.
Outset Medical to Present at the Goldman Sachs 45th Annual …
Jun 3, 2024 · SAN JOSE, Calif.--(BUSINESS WIRE)--Jun. 3, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the Goldman Sachs 45 th annual Healthcare conference on Wednesday, June 12, 2024 ...
Outset Medical | Tablo in the ICU
INDICATIONS FOR USE: The Tablo ® Hemodialysis System and TabloCart™ is indicated for use in patients with acute and/or chronic renal failure, with or without ultrafiltration, in an acute or chronic care facility. Treatments must be administered under physician’s prescription and observed by a trained individual who is considered competent in the use of the device.
Outset Medical Named to Fast Company’s First-Ever List of the …
Nov 18, 2021 · Outset is reinventing how dialysis is delivered to patients. Specifically designed to simplify dialysis treatment for patients and providers, the Tablo ® Hemodialysis System is a first-of-its-kind enterprise solution that is approved for use across the entire continuum of care — from hospital to home.
Environmental, Social and Governance | Outset Medical, Inc.
“At Outset, our ESG journey is rooted in our mission to catalyze permanent and profound change in where, when, and how dialysis is delivered to lower costs and restore identity, agency, and self-worth to patients.”